دورية أكاديمية
أعرض في EDS

Meta-analysis of cardiac magnetic resonance in prognosticating left ventricular function in peripartum cardiomyopathy.

التفاصيل البيبلوغرافية
العنوان: Meta-analysis of cardiac magnetic resonance in prognosticating left ventricular function in peripartum cardiomyopathy.
المؤلفون: Prameswari HS; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia., Kamarullah W; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia., Pranata R; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia., Putra ICS; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia., Undarsa AC; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia., Iqbal M; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia., Dewi TI; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia., Kusumawardhani NY; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia.; Department of Internal Medicine, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia., Akbar MR; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia., Astuti A; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia.
المصدر: ESC heart failure [ESC Heart Fail] 2024 Sep 18. Date of Electronic Publication: 2024 Sep 18.
Publication Model: Ahead of Print
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: John Wiley & Sons Ltd on behalf of the European Society of Cardiology Country of Publication: England NLM ID: 101669191 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2055-5822 (Electronic) Linking ISSN: 20555822 NLM ISO Abbreviation: ESC Heart Fail Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Oxford] : John Wiley & Sons Ltd on behalf of the European Society of Cardiology, [2014]-
مستخلص: Aims: Peripartum cardiomyopathy (PPCM) may result in a number of detrimental adverse cardiovascular events, notably persistent left ventricular ejection fraction (LVEF) reduction or even mortality. Imaging parameters on cardiac magnetic resonance (CMR) and their prognostic implications have rarely been perused in PPCM. We aimed to describe CMR's prognostic value in predicting poor left ventricular (LV) function recovery using late gadolinium enhancement (LGE) and T2-weighted or T2 mapping.
Methods and Results: PubMed, Europe PMC, and ScienceDirect were screened for studies on late gadolinium enhancement (LGE) and myocardial oedema using CMR and PPCM. The outcome of interest was poor LV function recovery, with a follow-up period of at least 6 months. Comparisons between groups with the presence of LGE, myocardial oedema, and recovered against non-recovered patients were pooled. A random-effects model was employed to calculate the effect size. All pooled results were expressed as risk ratios (RRs) and 95% confidence intervals (CI). The area under the curve (AUC) was generated to test overall prognostic accuracy. Six cohort studies with 162 patients were included. The mean age of participants in this study was 30.6 years, and the majority of patients were diagnosed with PPCM after delivery. LGE was associated with a higher risk of poor LV function recovery, particularly when conducted at a later stage of disease (≥2.8 months) [RR = 2.83 (95% CI = 1.25-6.40); P = 0.001]. On the contrary, CMR conducted early (<2.8 months) exhibited a greater predictive value for myocardial oedema perceived by T2 mapping [RR = 3.44 (95% CI = 1.04-11.34); P = 0.043]. Diagnostic-test accuracy meta-analysis revealed that LGE had a sensitivity of 73% (95% CI, 56-85%), specificity of 79% (95% CI, 45-95%), and AUC of 0.78 (95% CI, 0.75-0.82) in predicting poor LV recovery when performed in the later phase, whereas significant myocardial oedema in those with non-recovered LV function had a sensitivity of 12% (95% CI, 2-52%), specificity of 68% (95% CI, 39-88%), and AUC of 0.40 (95% CI, 0.36-0.44) while undertaken in the latter phase. Our findings support the notion that inflammation plays a significant role in PPCM and that alterations to tissue composition occur in a time-dependent manner.
Conclusions: Contrast-enhanced CMR can be utilized as an adjunct examination in post-partum PPCM patients to stratify the risk of poor LV function recovery while conducted at a suitable point in time.
(© 2024 The Author(s). ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.)
References: Sliwa K, Petrie MC, van der Meer P, Mebazaa A, Hilfiker‐Kleiner D, Jackson AM, et al. Clinical presentation, management, and 6‐month outcomes in women with peripartum cardiomyopathy: An ESC EORP registry. Eur Heart J 2020;41:3787‐3797. doi:10.1093/eurheartj/ehaa455.
Bauersachs J, König T, van der Meer P, Petrie MC, Hilfiker‐Kleiner D, Mbakwem A, et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: A position statement from the heart failure Association of the European Society of cardiology study group on peripartum cardiomyopathy. Eur J Heart Fail 2019;21:827‐843. doi:10.1002/ejhf.1493.
Stergiopoulos K, Lima FV. Peripartum cardiomyopathy‐diagnosis, management, and long term implications. Trends Cardiovasc Med 2019;29:164‐173. doi:10.1016/j.tcm.2018.07.012.
Sliwa K, Petrie MC, Hilfiker‐Kleiner D, Mebazaa A, Jackson A, Johnson MR, et al. Long‐term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: Practical guidance paper from the heart failure Association of the European Society of cardiology study group on peripartum cardiomyopathy. Eur J Heart Fail 2018;20:951‐962. doi:10.1002/ejhf.1178.
Hilfiker‐Kleiner D, Haghikia A, Masuko D, Nonhoff J, Held D, Libhaber E, et al. Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy. Eur J Heart Fail 2017;19:1723‐1728. doi:10.1002/ejhf.808.
Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum cardiomyopathy: JACC state‐of‐the‐art review. J Am Coll Cardiol 2020;75:207‐221. doi:10.1016/j.jacc.2019.11.014.
Goland S, Modi K, Bitar F, Janmohamed M, Mirocha JM, Czer LSC, et al. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail 2009;15:645‐650. doi:10.1016/j.cardfail.2009.03.008.
Becker MAJ, Cornel JH, van de Ven PM, van Rossum AC, Allaart CP, Germans T. The prognostic value of late gadolinium‐enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: A review and meta‐analysis. JACC Cardiovasc Imaging 2018;11:1274‐1284. doi:10.1016/j.jcmg.2018.03.006.
Shanbhag SM, Greve AM, Aspelund T, Schelbert EB, Cao JJ, Danielsen R, et al. Prevalence and prognosis of ischaemic and non‐ischaemic myocardial fibrosis in older adults. Eur Heart J 2019;40:529‐538. doi:10.1093/eurheartj/ehy713.
Xu H, Zhao L, Fu H, Xu R, Xie L, Zhang K, et al. Prognostic value of cardiac MRI late gadolinium enhancement in patients with peripartum cardiomyopathy: A retrospective study. Curr Probl Cardiol 2023;48:101587. doi:10.1016/j.cpcardiol.2023.101587.
Arora NP, Mohamad T, Mahajan N, Danrad R, Kottam A, Li T, et al. Cardiac magnetic resonance imaging in peripartum cardiomyopathy. Am J Med Sci 2014;347:112‐117.
Ersbøll AS, Johansen M, Damm P, Rasmussen S, Vejlstrup NG, Gustafsson F. Peripartum cardiomyopathy in Denmark: A retrospective, population‐based study of incidence, management and outcome. Eur J Heart Fail 2017;19:1712‐1720. doi:10.1002/ejhf.882.
Schelbert EB, Elkayam U, Cooper LT, Givertz MM, Alexis JD, Briller J, et al. Myocardial damage detected by late gadolinium enhancement cardiac magnetic resonance is uncommon in peripartum cardiomyopathy. J Am Heart Assoc 2017;6:e005472. doi:10.1161/JAHA.117.005472.
Haghikia A, Röntgen P, Vogel‐Claussen J, Schwab J, Westenfeld R, Ehlermann P, et al. Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: A cardiovascular magnetic resonance study. ESC Heart Fail 2015;2:139‐149. doi:10.1002/ehf2.12059.
Renz DM, Röttgen R, Habedank D, Wagner M, Böttcher J, Pfeil A, et al. New insights into peripartum cardiomyopathy using cardiac magnetic resonance imaging. Rofo 2011;183:834‐841. doi:10.1055/s‐0031‐1281600.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021;372:n71. doi:10.1136/bmj.n71.
Jenista ER, Wendell DC, Azevedo CF, Klem I, Judd RM, Kim RJ, et al. Revisiting how we perform late gadolinium enhancement CMR: insights gleaned over 25 years of clinical practice. J Cardiovasc Magn Reson 2023;25:18. doi:10.1186/s12968‐023‐00925‐0.
Kwon DH, Halley CM, Carrigan TP, Zysek V, Popovic ZB, Setser R, et al. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: A delayed hyperenhancement cardiac magnetic resonance study. JACC Cardiovasc Imaging 2009;2:34‐44. doi:10.1016/j.jcmg.2008.09.010.
Montant P, Sigovan M, Revel D, Douek P. MR imaging assessment of myocardial edema with T2 mapping. Diagn Interv Imaging 2015;96:885‐890. doi:10.1016/j.diii.2014.07.008.
Verhaert D, Thavendiranathan P, Giri S, Mihai G, Rajagopalan S, Simonetti OP, et al. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging 2011;4:269‐278. doi:10.1016/j.jcmg.2010.09.023.
McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, et al. Clinical outcomes for peripartum cardiomyopathy in North America: Results of the IPAC study (investigations of pregnancy‐associated cardiomyopathy). J Am Coll Cardiol 2015;66:905‐914. doi:10.1016/j.jacc.2015.06.1309.
Stang A. Critical evaluation of the Newcastle‐Ottawa scale for the assessment of the quality of nonrandomized studies in meta‐analyses. Eur J Epidemiol 2010;25:603‐605. doi:10.1007/s10654‐010‐9491‐z.
Cochrane Handbook for Systematic Reviews of Interventions [Internet]. [cited 2022 Sep 22]. Available from: https://training.cochrane.org/handbook. Accessed 22 February 2024.
Liang YD, Xu YW, Li WH, Wan K, Sun JY, Lin JY, et al. Left ventricular function recovery in peripartum cardiomyopathy: A cardiovascular magnetic resonance study by myocardial T1 and T2 mapping. J Cardiovasc Magn Reson 2020;22:2. doi:10.1186/s12968‐019‐0590‐z.
Isaak A, Ayub TH, Merz WM, Faron A, Endler C, Sprinkart AM, et al. Peripartum cardiomyopathy: Diagnostic and prognostic value of cardiac magnetic resonance in the acute stage. Diagnostics (Basel) 2022;12:378. doi:10.3390/diagnostics12020378.
Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales‐Villa R, Basso C, et al. 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J 2023;44:3503‐3626. doi:10.1093/eurheartj/ehad194.
Lupu S, Pop M, Mitre A. Loeffler endocarditis causing heart failure with preserved ejection fraction (HFpEF): Characteristic images and diagnostic pathway. Diagnostics (Basel) 2022;12:2157. doi:10.3390/diagnostics12092157.
Kawano H, Tsuneto A, Koide Y, Tasaki H, Sueyoshi E, Sakamoto I, et al. Magnetic resonance imaging in a patient with peripartum cardiomyopathy. Intern Med 2008;47:97‐102. doi:10.2169/internalmedicine.47.0316.
Lamparter S, Pankuweit S, Maisch B. Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol 2007;118:14‐20. doi:10.1016/j.ijcard.2006.04.090.
Ntusi NBA, Mayosi BM. Aetiology and risk factors of peripartum cardiomyopathy: A systematic review. Int J Cardiol 2009;131:168‐179. doi:10.1016/j.ijcard.2008.06.054.
Sliwa K, Bauersachs J, Arany Z, Spracklen TF, Hilfiker‐Kleiner D. Peripartum cardiomyopathy: From genetics to management. Eur Heart J 2021;42:3094‐3102. doi:10.1093/eurheartj/ehab458.
Ricci F, de Innocentiis C, Verrengia E, Ceriello L, Mantini C, Pietrangelo C, et al. The role of multimodality cardiovascular imaging in peripartum cardiomyopathy. Front Cardiovasc Med [Internet] 2020;7:4. doi:10.3389/fcvm.2020.00004.
Petryka‐Mazurkiewicz J, Kryczka K, Mazurkiewicz Ł, Miłosz‐Wieczorek B, Śpiewak M, Marczak M, et al. Cardiovascular magnetic resonance in peripartum cardiomyopathy: Comparison with idiopathic dilated cardiomyopathy. Diagnostics (Basel) 2021;11:1752. doi:10.3390/diagnostics11101752.
Zagrosek A, Abdel‐Aty H, Boyé P, Wassmuth R, Messroghli D, Utz W, et al. Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging 2009;2:131‐138. doi:10.1016/j.jcmg.2008.09.014.
Friedrich MG, Sechtem U, Schulz‐Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: A JACC white paper. J Am Coll Cardiol 2009;53:1475‐1487. doi:10.1016/j.jacc.2009.02.007.
Elkayam U, Goland S. Bromocriptine for the treatment of peripartum cardiomyopathy. Circulation 2010;121:1463‐1464. doi:10.1161/CIR.0b013e3181db2f07.
Lovell JP, Bermea K, Yu J, Rousseau S, Cohen CD, Bhalodia A, et al. Serum proteomic analysis of peripartum cardiomyopathy reveals distinctive dysregulation of inflammatory and cholesterol metabolism pathways. JACC: Heart Failure 2023;11:1231‐1242. doi:10.1016/j.jchf.2023.05.031.
Basu J, Redman C, Ormerod O. Immunosuppression therapy in the management of peripartum cardiomyopathy: A case series and literature review. Obstet Med 2016;9:174‐176. doi:10.1177/1753495X16655915.
Halliday BP, Wassall R, Lota AS, Khalique Z, Gregson J, Newsome S, et al. Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED‐HF): An open‐label, pilot, randomised trial. The Lancet 2019;393:61‐73. doi:10.1016/S0140‐6736(18)32484‐X.
Mirelis JG, Escobar‐Lopez L, Ochoa JP, Espinosa MÁ, Villacorta E, Navarro M, et al. Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non‐ischaemic dilated cardiomyopathy. Eur J Heart Fail 2022;24:1183‐1196. doi:10.1002/ejhf.2514.
Halliday BP, Baksi AJ, Gulati A, Ali A, Newsome S, Izgi C, et al. Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement. JACC Cardiovasc Imaging 2019;12:1645‐1655. doi:10.1016/j.jcmg.2018.07.015.
Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004;159:882‐890. doi:10.1093/aje/kwh101.
فهرسة مساهمة: Keywords: Cardiac magnetic resonance; Late gadolinium enhancement; Left ventricular function recovery; Peripartum cardiomyopathy; T2 mapping
تواريخ الأحداث: Date Created: 20240919 Latest Revision: 20240919
رمز التحديث: 20240919
DOI: 10.1002/ehf2.15024
PMID: 39295149
قاعدة البيانات: MEDLINE
الوصف
تدمد:2055-5822
DOI:10.1002/ehf2.15024